UAE Heart Failure Treatment Drugs Market includes Production and Market Share by Type (2021-2027)

Industrial Growth Forecast Report UAE Heart Failure Treatment Drugs Market 2021-2027: The Global UAE Heart Failure Treatment Drugs Report provides Insightful information to the clients enhancing their basic leadership capacity identified with the global UAE Heart Failure Treatment Drugs business, including market dynamics, segmentation, competition, and regional growth. The strategy of expansion has been adopted by key players who are increasing their production capacities to cater to the increasing demand for various application.

Request Here For PDF Brochure

Rising expenditure on the healthcare sector is expected to drive growth of the UAE heart failure treatment drugs market over the forecast period. In October 2019, as per the Healthcare Resource Guide, the expenditure on the healthcare sector in UAE has increased by 5.4% from 2018 reaching a total of US$ 14.4 billion as of 2019. In 2018, as reported by the Non-Communicable Diseases (NCD) Country Profiles of World Health Organization (WHO), cardiovascular diseases were the major cause of deaths in the UAE, accounting about 40% of the overall mortality rate.
Furthermore, rising incidences of cardiovascular diseases in the UAE are expected to grow the risk of heart failures. Factors such as inactive lifestyles, unhealthy appetite, and smoking habits are all increasing the menace of heart failure across the Middle Eastern population. In 2018, as reported by the Non-Communicable Diseases (NCD) Country Profiles of World Health Organization (WHO), cardiovascular diseases were the major cause of deaths in the UAE, accounting about 40% of the overall mortality rate.

Opportunities

Besides the rising competition and quick expansion of pharmaceutical production, UAE needs to import 80% of medical products to cope up with demand of drugs in the country.

In 2018, a new regulation was introduced in Abu Dhabi for generic prescription. It described that every pharmaceutical company in the country must supply generic medicines to the patients; and those companies willing to supply branded medications, should pay for the additional costs that may be about 70% higher than the generic medications.

This regulation will allow the regional pharmaceutical companies to provide more variety of medicinal products to their customers at affordable price, hence, propelling the growth of the market.

Impact of COVID-19 epidemic

Since December 2019, the outbreak of SARS-CoV-2 virus has been transmitted to over 100 nations around the world and the World Health Organization (WHO) had declared it a public health emergency on March 11, 2020. As reported by the World Health Organization (WHO), the exhibition of the SARS-CoV-2 virus has led to over 26.1 million infections across the globe as of September, 2020.

COVID-19 pandemic has majorly impacted the economy in three different ways; with its direct effect on manufacture and demand by creating disturbances in the supply chain, with its financial influence on the financial markets and firms. Following the national lockdowns, various countries such as Saudi Arabia, UAE, and Egypt have been facing issues associated with drug transportation among these countries.

The COVID-19 epidemic and its consequent lockdowns in several nations across the world has affected the financial position of businesses of every sectors. The pandemic has significantly impacted the private healthcare sector.

Browse 06 Market Data Tables and 16 Figures spread through 112 Pages and in-depth TOC on “UAE Heart Failure Treatment Drugs Market, by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Drug Class (Beta Blockers, ACE Inhibitors, Diuretics, Angiotensin 2 Receptor Blockers, Inotropes, Aldosterone Antagonists, and Others).

Key Takeaways of the UAE Heart Failure Treatment Drugs Market:

Due to vigorous products in the pipeline and rising approvals of newer drugs for heart failure, the UAE heart failure treatment market is expected to manifest a CAGR of 5% over the forecast period.

According to the class of drug: Due to launch of newer and advanced products by major players of the market, the ACE inhibitors segment is expected to maintain its dominating position in the UAE heart failure treatment drugs market by 2027.
According to distribution channel: The hospital pharmacies segment is poised to hold its dominant position in the UAE heart failure treatment drugs market by 2027, as the hospital pharmacies mostly rely on hospitals to medication procurement for out-patients as well as in-patients.

Major Key Players Include In UAE Heart Failure Treatment Drugs Market: Novartis International AG, AstraZeneca Plc., Amgen, Inc., Pfizer, Inc., Mylan N.V., Merck & Co., Inc., Bristol-Myers Squibb, GlaxoSmithKline Plc., and Teva Pharmaceutical Industries Ltd.

Buy instant copy of this research report with Flat US $ 2000 Off@ – https://www.coherentmarketinsights.com/promo/buynow/4172

Main points in UAE Heart Failure Treatment Drugs Market Report Table of Content

Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 UAE Heart Failure Treatment Drugs Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: UAE Heart Failure Treatment Drugs Industry Impact

Chapter 2 Global UAE Heart Failure Treatment Drugs Competition by Types, Applications, and Top Regions and Countries
2.1 Global UAE Heart Failure Treatment Drugs (Volume and Value) by Type
2.3 Global UAE Heart Failure Treatment Drugs (Volume and Value) by Regions

Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis

Chapter 4 Global UAE Heart Failure Treatment Drugs Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America UAE Heart Failure Treatment Drugs Market Analysis
Chapter 6 East Asia UAE Heart Failure Treatment Drugs Market Analysis
Chapter 7 Europe UAE Heart Failure Treatment Drugs Market Analysis
Chapter 8 South Asia UAE Heart Failure Treatment Drugs Market Analysis
Chapter 9 Southeast Asia UAE Heart Failure Treatment Drugs Market Analysis
Chapter 10 Middle East UAE Heart Failure Treatment Drugs Market Analysis
Chapter 11 Africa UAE Heart Failure Treatment Drugs Market Analysis
Chapter 12 Oceania UAE Heart Failure Treatment Drugs Market Analysis
Chapter 13 South America UAE Heart Failure Treatment Drugs Market Analysis
Chapter 14 Company Profiles and Key Figures in UAE Heart Failure Treatment Drugs Business
Chapter 15 Global UAE Heart Failure Treatment Drugs Market Forecast (2021-2027)
Chapter 16 Conclusions
Research Methodology

Request for a Sample Report

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com